MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Aptamer wins deals; DSW beats market view

ALN

The following stocks are the leading risers and fallers on AIM on Thursday.

----------

AIM - WINNERS

----------

Aptamer Group PLC, up 8.8% at 0.37 pence, 12-month range 0.20p-0.95p. The biotechnology firm announces two new fee-for-service development contracts with existing customers. They are worth £231,000 in total. Aptamer, which produces synthetic binders for the life science industry, also says it has struck terms with a provider of speciality enzymes for developed enzyme-modulating Optimer binders. ‘The first of the two new development contracts, valued at up to £105,000, focuses on creating additional enzyme-modulating Optimers to broaden the customer’s reagent offering. This is the second project with this customer. The second development contract is with a top 20 global pharmaceutical company. Valued at up to £126,000, this new fee-for-service development project will involve the development of Optimer reagents targeting a small molecule for use in the customer’s internal research programmes,’ Aptamer explains. In the deal with the enzyme provider, Aptamer says the pact includes undisclosed milestone payments and a 10% royalty on sales of all Optimer-containing products.

----------

DSW Capital PLC, up 7.8% at 55.00p, 12-month range 40.60p-77.00p. The provider of professional services via the Dow Schofield Watts and DR Solicitors brands expects to report forecast-topping earnings. DSW expects to report network revenue for the year ended March 31 of £25.8 million, a record, jumping 61% from £16.0 million. It will be an outcome ‘ahead of market expectations’. Adjusted earnings before interest, tax, depreciation and amortisation are expected to have surged to £1.8 million from £600,000, an outcome also ahead of forecasts. ‘The global economic disruption may create a more challenging M&A market in the year ahead, but we are committed to turning those challenges into opportunities in recruitment, which slowed in FY25 due to the abnormally high activity levels. Our reliance on M&A revenues, however, is much reduced by the addition of DR Solicitors with its more predictable revenues, and we have a more balanced business as we enter FY26,’ Chief Executive Officer Shru Morris says.

----------

AIM - LOSERS

----------

Pebble Group PLC, down 4.2% at 34.50p, 12-month range 34.00p-65.00p. The provider of technology and services for the promotional products industry hits a 12-month low on Thursday. The shares have gone ex-dividend, meaning new buyers will not qualify for the latest payout. Shares are down 24% so far in 2025.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.